Orthopedic Implants Market Size to Reach US $64 Billion by 2026; Rising Number of Orthopedic Sports Injuries to Favor Growth

    NEXT STORY
    Y-mAbs Announces Update on Omburtamab in DSRCT
    PREV STORY
    Anchiano Discontinues Phase 2 Codex Study Evaluating Inodiftagene Vixteplasmid in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC); Company Focuses on Advancing Pan-RAS Inhibitor Program
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    XOMA Reports Fourth Quarter and Full Year 2016 Financial Results

    Actions taken in 2016 set the stage for reduced operating costs and capital requirements ...

    author_avatar
    NASDAQ Market News

    Oshkosh Physician Attends National Physicians Council for Healthcare Policy Meeting in Washington, D.C.

    TUCSON, Ariz., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Albert L. Fisher, M.D., of Oshkosh, ...

    author_avatar
    NASDAQ Market News

    Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer

    author_avatar
    NASDAQ Market News